Vito R.
- Country
- Italy
- Department
- Ophthalology
Research Overview
- Evaluation of Timbetasin Acetate Ophthalmic Solution 0.1% for Neurotrophic Keratopathy: A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study
- SEER-3: A Phase 3, Multi-Center, Randomized, Parallel, Double Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of Neurotrophic Keratopathy
Data & Insights
Has run more than one trial at 7 of 24 partner sites.
Specializations
Ophthalmology Focus
The investigator specializes in the research and treatment of neurotrophic keratopathy, a rare degenerative corneal condition affecting eye health and vision.
- Corneal Disease Management
- Ocular Surface Disorders
- Vision Preservation Therapies
Expertise in evaluating innovative ophthalmic solutions for corneal conditions.
Therapeutic Development
Focused on advancing treatment options for degenerative eye conditions, particularly through the investigation of novel ophthalmic solutions.
- Clinical Therapeutics
- Ophthalmic Formulations
- Treatment Safety Assessment
Dedicated to exploring new therapeutic approaches for rare ocular disorders.
Clinical Expertise
Conducts research in advanced eye care with particular emphasis on treating complex corneal conditions.
- Rare Eye Disease Management
- Corneal Healing Studies
- Visual Function Preservation
Experience in evaluating therapeutic interventions for challenging ophthalmic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.